Barbara Voetsch, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vertigo | 2 | 2021 | 198 | 0.790 |
Why?
|
| Somatosensory Disorders | 1 | 2021 | 48 | 0.750 |
Why?
|
| Dizziness | 2 | 2021 | 247 | 0.740 |
Why?
|
| Glutathione Peroxidase | 5 | 2007 | 254 | 0.690 |
Why?
|
| Neurologic Examination | 2 | 2021 | 911 | 0.670 |
Why?
|
| Intracranial Thrombosis | 5 | 2020 | 109 | 0.600 |
Why?
|
| Stroke | 14 | 2022 | 9905 | 0.510 |
Why?
|
| Thrombophilia | 4 | 2007 | 307 | 0.440 |
Why?
|
| Brain Ischemia | 6 | 2022 | 3130 | 0.410 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2011 | 50 | 0.380 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 1054 | 0.340 |
Why?
|
| Polymorphism, Genetic | 3 | 2006 | 4286 | 0.340 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2021 | 1027 | 0.340 |
Why?
|
| Vasospasm, Intracranial | 1 | 2011 | 210 | 0.330 |
Why?
|
| Intracranial Aneurysm | 2 | 2021 | 1239 | 0.300 |
Why?
|
| Aryldialkylphosphatase | 2 | 2004 | 63 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 4 | 2007 | 5793 | 0.270 |
Why?
|
| Venous Thrombosis | 4 | 2007 | 1281 | 0.250 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2004 | 14 | 0.240 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2004 | 110 | 0.210 |
Why?
|
| Intracranial Embolism | 2 | 2020 | 192 | 0.210 |
Why?
|
| Esterases | 1 | 2002 | 93 | 0.210 |
Why?
|
| Thrombectomy | 3 | 2022 | 699 | 0.200 |
Why?
|
| Blood Vessels | 2 | 2004 | 1113 | 0.200 |
Why?
|
| Hemodynamics | 1 | 2011 | 4186 | 0.190 |
Why?
|
| Central Nervous System Infections | 1 | 2021 | 61 | 0.180 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2021 | 1188 | 0.180 |
Why?
|
| Open Reading Frames | 1 | 2004 | 813 | 0.180 |
Why?
|
| Arteries | 2 | 2002 | 1115 | 0.170 |
Why?
|
| Thrombosis | 2 | 2004 | 3033 | 0.170 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2003 | 758 | 0.170 |
Why?
|
| Middle Cerebral Artery | 3 | 2011 | 265 | 0.160 |
Why?
|
| Nitric Oxide | 2 | 2005 | 2114 | 0.160 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2020 | 483 | 0.160 |
Why?
|
| Paresis | 2 | 2011 | 176 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 1484 | 0.150 |
Why?
|
| Thrombolytic Therapy | 3 | 2021 | 2099 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2007 | 17707 | 0.140 |
Why?
|
| Gene Frequency | 4 | 2006 | 3588 | 0.140 |
Why?
|
| Intracranial Hemorrhages | 1 | 2021 | 844 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 600 | 0.120 |
Why?
|
| Apolipoprotein E4 | 1 | 2018 | 690 | 0.120 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 880 | 0.120 |
Why?
|
| Cerebral Angiography | 2 | 2011 | 1260 | 0.110 |
Why?
|
| Fibrinolytic Agents | 2 | 2021 | 2167 | 0.110 |
Why?
|
| Glucosephosphate Dehydrogenase | 2 | 2005 | 210 | 0.110 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2011 | 48 | 0.100 |
Why?
|
| Ischemia | 1 | 2000 | 1893 | 0.090 |
Why?
|
| Haplotypes | 2 | 2007 | 2758 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2018 | 1802 | 0.090 |
Why?
|
| Registries | 2 | 2021 | 8405 | 0.090 |
Why?
|
| Dominance, Cerebral | 1 | 2011 | 627 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1896 | 0.090 |
Why?
|
| Cerebellum | 1 | 2017 | 1494 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2021 | 2292 | 0.080 |
Why?
|
| Blood Patch, Epidural | 1 | 2009 | 56 | 0.080 |
Why?
|
| Intracranial Hypotension | 1 | 2009 | 40 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 1489 | 0.080 |
Why?
|
| Demography | 2 | 2004 | 1646 | 0.080 |
Why?
|
| Antioxidants | 2 | 2006 | 1649 | 0.080 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2007 | 62 | 0.070 |
Why?
|
| Risk Factors | 11 | 2020 | 73885 | 0.070 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2007 | 329 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2009 | 278 | 0.070 |
Why?
|
| Brazil | 2 | 2002 | 1194 | 0.070 |
Why?
|
| Humans | 34 | 2022 | 755800 | 0.070 |
Why?
|
| Logistic Models | 3 | 2007 | 13316 | 0.060 |
Why?
|
| Coagulation Protein Disorders | 1 | 2004 | 6 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2017 | 2778 | 0.060 |
Why?
|
| Hospitalization | 2 | 2021 | 10684 | 0.060 |
Why?
|
| Cranial Sinuses | 1 | 2004 | 68 | 0.060 |
Why?
|
| Epoprostenol | 1 | 2005 | 250 | 0.060 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 7776 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2018 | 5994 | 0.060 |
Why?
|
| Hormones | 1 | 2007 | 871 | 0.060 |
Why?
|
| Adult | 14 | 2021 | 218056 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2021 | 36071 | 0.050 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2004 | 136 | 0.050 |
Why?
|
| Fibrinolysis | 1 | 2004 | 332 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
| Apyrase | 1 | 2005 | 369 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
| Cerebral Infarction | 2 | 2005 | 982 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1172 | 0.050 |
Why?
|
| Endarterectomy, Carotid | 1 | 2007 | 553 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 695 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 908 | 0.050 |
Why?
|
| Hyperhomocysteinemia | 1 | 2002 | 118 | 0.050 |
Why?
|
| Middle Aged | 13 | 2022 | 218133 | 0.050 |
Why?
|
| Glutamine | 1 | 2004 | 573 | 0.050 |
Why?
|
| Female | 17 | 2021 | 388048 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 673 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3600 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2004 | 9721 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 2006 | 1154 | 0.050 |
Why?
|
| Pandemics | 4 | 2021 | 8570 | 0.050 |
Why?
|
| Cerebral Veins | 1 | 2002 | 155 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2007 | 1408 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 1758 | 0.040 |
Why?
|
| Male | 17 | 2021 | 356684 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2006 | 2607 | 0.040 |
Why?
|
| Arginine | 1 | 2004 | 934 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2000 | 61 | 0.040 |
Why?
|
| Lymphokines | 1 | 2003 | 929 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2004 | 512 | 0.040 |
Why?
|
| Alleles | 2 | 2002 | 6890 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 25704 | 0.040 |
Why?
|
| Prothrombin | 1 | 2000 | 190 | 0.040 |
Why?
|
| Recurrence | 1 | 2011 | 8446 | 0.040 |
Why?
|
| Factor V | 1 | 2000 | 167 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2011 | 20415 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 3343 | 0.040 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2000 | 276 | 0.040 |
Why?
|
| Genotype | 2 | 2004 | 12894 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2022 | 79735 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2004 | 901 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4045 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2004 | 2936 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2018 | 149 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 4116 | 0.040 |
Why?
|
| Linoleic Acid | 1 | 2018 | 159 | 0.040 |
Why?
|
| Africa | 1 | 2000 | 698 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 1735 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 1917 | 0.040 |
Why?
|
| Contraceptives, Oral | 1 | 2000 | 554 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2018 | 435 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 2107 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2007 | 2716 | 0.030 |
Why?
|
| Living Donors | 1 | 2021 | 630 | 0.030 |
Why?
|
| North America | 1 | 2020 | 1284 | 0.030 |
Why?
|
| Nystagmus, Pathologic | 1 | 2017 | 104 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 1337 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1648 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2011 | 8504 | 0.030 |
Why?
|
| Aged | 9 | 2021 | 167433 | 0.030 |
Why?
|
| Canada | 1 | 2021 | 2121 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 1067 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2007 | 2651 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 4423 | 0.030 |
Why?
|
| Homozygote | 1 | 2000 | 1786 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 233 | 0.030 |
Why?
|
| Family Health | 1 | 2000 | 1261 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 58563 | 0.030 |
Why?
|
| Tinnitus | 1 | 2017 | 192 | 0.030 |
Why?
|
| Point Mutation | 1 | 2000 | 1596 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 3911 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6066 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2022 | 64560 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2005 | 2500 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2017 | 641 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 2523 | 0.030 |
Why?
|
| Prevalence | 2 | 2002 | 15596 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2005 | 3064 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2004 | 2728 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2006 | 3521 | 0.030 |
Why?
|
| Brain | 3 | 2009 | 26743 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2021 | 54015 | 0.030 |
Why?
|
| Cleft Lip | 1 | 2018 | 503 | 0.030 |
Why?
|
| Adolescent | 4 | 2007 | 87249 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2000 | 1166 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4722 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 663 | 0.030 |
Why?
|
| Retinal Diseases | 1 | 2018 | 701 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 2292 | 0.020 |
Why?
|
| Docosahexaenoic Acids | 1 | 2018 | 905 | 0.020 |
Why?
|
| Risk | 1 | 2004 | 9625 | 0.020 |
Why?
|
| Age Distribution | 1 | 2017 | 2887 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1178 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2004 | 10180 | 0.020 |
Why?
|
| Boston | 1 | 2004 | 9259 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2018 | 1986 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 1494 | 0.020 |
Why?
|
| Time Factors | 3 | 2021 | 39975 | 0.020 |
Why?
|
| Survival Rate | 1 | 2004 | 12784 | 0.020 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2009 | 37 | 0.020 |
Why?
|
| Head-Down Tilt | 1 | 2009 | 65 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 5732 | 0.020 |
Why?
|
| Hernia | 1 | 2009 | 69 | 0.020 |
Why?
|
| Child | 3 | 2006 | 79453 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2004 | 10393 | 0.020 |
Why?
|
| Prognosis | 3 | 2005 | 29430 | 0.020 |
Why?
|
| Comorbidity | 1 | 2002 | 10538 | 0.020 |
Why?
|
| Unconsciousness | 1 | 2009 | 219 | 0.020 |
Why?
|
| Mortality | 1 | 2018 | 2901 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 21910 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 518 | 0.020 |
Why?
|
| Mutation | 2 | 2007 | 29817 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4866 | 0.020 |
Why?
|
| Animals | 4 | 2004 | 167168 | 0.020 |
Why?
|
| Brain Edema | 1 | 2009 | 603 | 0.020 |
Why?
|
| Catalase | 1 | 2005 | 210 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2005 | 94 | 0.010 |
Why?
|
| Craniotomy | 1 | 2009 | 741 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2000 | 6517 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2004 | 41911 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18369 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 2226 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12502 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2004 | 190 | 0.010 |
Why?
|
| Tremor | 1 | 2004 | 187 | 0.010 |
Why?
|
| Selenocysteine | 1 | 2004 | 127 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 2004 | 304 | 0.010 |
Why?
|
| Ear Diseases | 1 | 2004 | 176 | 0.010 |
Why?
|
| United States | 2 | 2021 | 71902 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 2004 | 300 | 0.010 |
Why?
|
| Perfusion | 1 | 2007 | 1372 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 586 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 718 | 0.010 |
Why?
|
| Pregnancy | 2 | 2004 | 29548 | 0.010 |
Why?
|
| Ataxia | 1 | 2004 | 306 | 0.010 |
Why?
|
| Infant | 1 | 2004 | 35883 | 0.010 |
Why?
|
| RNA, Transfer | 1 | 2004 | 289 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 749 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2004 | 659 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 3276 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1991 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 23960 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 458 | 0.010 |
Why?
|
| Smoking | 1 | 2017 | 9053 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2004 | 962 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 1532 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2007 | 862 | 0.010 |
Why?
|
| Severity of Illness Index | 3 | 2005 | 15753 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2017 | 12840 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 15658 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 3849 | 0.010 |
Why?
|
| Hypertension | 1 | 2017 | 8539 | 0.010 |
Why?
|
| Headache | 1 | 2004 | 1239 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 5784 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4448 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 6046 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2004 | 1895 | 0.010 |
Why?
|
| Heart Rate | 1 | 2005 | 4107 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 58041 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 6975 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 12444 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 3473 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 17610 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7589 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 5183 | 0.010 |
Why?
|
| Pain | 1 | 2004 | 5002 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12928 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 15647 | 0.010 |
Why?
|
| Kidney | 1 | 2004 | 7010 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15588 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13433 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 39189 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1997 | 15214 | 0.000 |
Why?
|